The global acute kidney injury treatment market  damage is anticipated to expand at a noteworthy 8% yearly growth rate between 2022 and 2029. The increasing prevalence of acute kidney injury and the ensuing rise in early diagnosis and treatment seeking rates are the main drivers of the worldwide acute renal injury treatment market. Dialysis and other treatments have made acute renal injury easier to manage and have helped reduce the chance of developing kidney-related diseases.

Various organisations are involved in acute kidney injury disease surveillance. In 2021, China’s central government issued the 13th Five Year National Science and Technology Innovation Plan, which aims to create a national platform to share biomedical big data, develop technologies for precision medicine, and integrate them into a multilevel knowledge database, leading the healthcare treatment market to new growth avenues.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14403

Key Takeaways:

• Owing to increasing acute kidney injury prevalence, number of dialysis centres, and efficient treatment method, the dialysis segment is expected to be a significant revenue generator.
• The intermittent haemodialysis segment, under product, in the acute kidney injury treatment market, is expected to be a prominent segment, as results provided by this treatment are more efficient as compared to other dialysis methods.
• The pre-renal injury segment is anticipated to dominate the acute kidney injury treatment market, as pre-renal injury is more prevalent in patients with acute kidney injury.
• North America is expected to dominate the global acute kidney injury treatment market in terms of revenue, owing to the growing adoption of advanced treatments over conventional methods. East Asia is expected to offer lucrative opportunities for the acute kidney injury treatment market during the forecast period.

Advanced Technology & Product Launches – Key Strategies Followed by Manufacturers

Advancements in diagnostic technology and more product availability in order to streamline their product offerings in respective regions with diverse product portfolios are being followed by players in the acute kidney injury treatment market. For instance, in January, 2022, Fresenius Medical Care launched the 4008A dialysis machine to improve accessibility to life-sustaining dialysis treatment.

Competitive Landscape

Leading players in the global acute kidney injury treatment market are focusing on developing automated, portable, and tech-driven dialysis equipment to deliver advanced care to patients. They are also integrating advanced technologies such as artificial intelligence and internet of things (IoT) to expand their product portfolio.

Meanwhile, some of the other players are making advancements in diagnostic technology in order to streamline their product offerings in emerging economies with diverse product portfolios.

Key Companies:

• Novartis, Pfizer Inc.
• Merck & Co.
• Biocon Ltd.
• Teva Pharmaceutical Industries Ltd.
• Mylan Pharmaceuticals Inc.
• NIPRO Medical
• Baxter Corporation
• Asahi Kasei
• NIKKISO
• Fresenius Medical Care
• Others

Acute Kidney Injury Treatment Market By Category

Product:

• Dialysis
• Intermittent Hemodialysis
• Continuous Renal Replacement Therapy (CRRT)
• Sustained Low-Efficiency Dialysis (SLED)
• Drug Therapy
• Antibiotics
• Diuretics
• Immunosuppressive Agents

Injury:

• Pre-renal Injury
• Intrinsic Renal Injury
• Post-renal Injury

Distribution Channel:

• Hospitals
• Ambulatory Surgical Centers
• Others

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa(MEA)